Abstract
The metabolic and physical properties of tumor cells that are associated with their ability to resist or escape from immune attack have been investigated. The susceptibility of P815 murine mastocytoma cells to immune killing can be modulated. Culturing the cells with adriamycin or with hydrocortisone increases or decreases, respectively, the sensitivity of the cells to killing by antibody (Ab) plus complement (C); in addition, culturing the cells with mitomycin C or hydrocortisone increases or decreases, respectively, the sensitivity of the cells to killing by cytotoxic T lymphocytes (CTL). The susceptibility of the cells to Ab-C killing correlates with the ability of the cells to synthesize complex cellular lipids, but not DNA, RNA, protein, or carbohydrate. Further, tumor cells rendered sensitive to Ab-C killing by adriamycin are decreased in total lipid content and in their cholesterol/phospholipid mole ratio; hydrocortisone-treated resistant cells showed the opposite effects. The ability of tumor cells to resist CTL killing did not correlate with their total cellular lipid synthesis, but did correlate with the synthesis and composition of specific cellular phospholipids. In addition, tumor cells increased in sensitivity to ...Continue Reading
References
Jul 1, 1978·Transplantation·B Schick, G Berke
Jan 1, 1975·The Journal of Membrane Biology·A RéthyV Tomasi
Jan 1, 1978·Contemporary Topics in Molecular Immunology·S H OhanianT Borsos
Jan 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·J L RubensteinH M McConnell
Dec 15, 1978·Biochimica Et Biophysica Acta·M Shinitzky, Y Barenholz
Feb 20, 1979·Biochimica Et Biophysica Acta·R P van HoevenP Emmelot
Jan 4, 1979·Biochimica Et Biophysica Acta·C M BallardJ P Dickinson
Jan 4, 1979·Biochimica Et Biophysica Acta·C M BallardJ J Smith
Jan 5, 1974·Journal of Molecular Biology·M Shinitzky, M Inbar
Mar 1, 1981·Cellular Immunology·S I Schlager
Jan 15, 1982·Cellular Immunology·S I Schlager
Sep 24, 1981·Biochimica Et Biophysica Acta·S I Schlager, H Jordi
Citations
Jan 1, 1987·Journal of Neuro-oncology·S K JacobsE A Grimm
Sep 1, 1991·Biulleten' eksperimental'noĭ biologii i meditsiny·I V KondakovaE V Antipova
Mar 3, 1988·Biochimica Et Biophysica Acta·A B KierF Schroeder
Jan 1, 1986·International Journal of Immunopharmacology·K L Erickson
Jan 1, 1986·International Journal of Immunopharmacology·J Y LerouxD Oth
Aug 1, 1985·Prostaglandins, Leukotrienes, and Medicine·M E BéginD F Horrobin
Nov 1, 1987·Prostaglandins, Leukotrienes, and Medicine·F FujiwaraS Imashuku
Jan 1, 1993·Nutrition and Cancer·A W PascaleL J Jenski
Jan 1, 1994·Archiv für Tierernährung·G I StanglA M Reichlmayr-Lais
Jul 12, 2007·Cell Division·Bradley S EllisonRobert J Boackle
Dec 19, 1984·Biochimica Et Biophysica Acta·W J Van BlitterswijkT Hengeveld
Jun 30, 1987·Biochimica Et Biophysica Acta·D OthC Bruneau
Jul 1, 1990·Medical Hypotheses·D F Horrobin
Oct 13, 2000·Biochimica Et Biophysica Acta·L J JenskiW Stillwell
Jun 11, 1985·Biochimica Et Biophysica Acta·W J van BlitterswijkJ de Widt
Sep 1, 1987·JPEN. Journal of Parenteral and Enteral Nutrition·K G Lundholm, C Drott
Feb 1, 1988·Cancer·A Topilko, B Caillou
Nov 5, 2019·Archives of Medical Research·Undurti N Das
Nov 17, 2019·Medical Hypotheses·Undurti N Das
Apr 30, 2020·Archives of Medical Research·Undurti N Das